Correction to: Cancer Gene Therapy https://doi.org/10.1038/s41417-023-00611-4, published online 17 April 2023
In this article, the author name He-chun Xia was incorrectly written as Xe-chun Xia.
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Yao, J., Hui, Jw., Chen, Yj. et al. Correction to: Lycium barbarum glycopeptide targets PER2 to inhibit lipogenesis in glioblastoma by downregulating SREBP1c. Cancer Gene Ther 30, 1178 (2023). https://doi.org/10.1038/s41417-023-00620-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41417-023-00620-3